• OPEN AN ACCOUNT
Indian Indices
Sensex
73,123.83 -125.56
( -0.17%)
Global Indices
Nasdaq
52,230.09 -658.89
(-1.25%)
Dow Jones
7,644.13 -40.30
(-0.52%)
Hang Seng
62,584.98 -322.86
(-0.51%)
Nikkei 225
10,670.63 -54.40
(-0.51%)
Forex
USD-INR
94.61 0.10
(0.11%)
EUR-INR
106.18 0.08
(0.07%)
GBP-INR
126.70 0.19
(0.15%)
JPY-INR
0.60 0.00
(0.70%)

EQUITY - MARKET SCREENER

Accent Microcell Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
92465
INE0Q5D01013
114.8377966
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ACCENTMIC
32.41
1421.35
EPS(TTM)
Face Value()
Div & Yield %
18.28
10
0.17
 

Everest Industries reports consolidated net loss of Rs 47.17 crore in the March 2026 quarter
May 27,2026
Net loss of Everest Industries reported to Rs 47.17 crore in the quarter ended March 2026 as against net profit of Rs 7.64 crore during the previous quarter ended March 2025. Sales declined 27.72% to Rs 327.17 crore in the quarter ended March 2026 as against Rs 452.63 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 101.69 crore in the year ended March 2026 as against net loss of Rs 3.60 crore during the previous year ended March 2025. Sales declined 17.75% to Rs 1417.00 crore in the year ended March 2026 as against Rs 1722.82 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales327.17452.63 -28 1417.001722.82 -18
OPM %-7.972.28 --2.681.74 -
PBDT-30.719.53 PL -56.8621.00 PL
PBT-42.08-2.17 -1839 -97.88-17.93 -446
NP-47.177.64 PL -101.69-3.60 -2725